What will be my microdosing schedule
I believe in your study that people necessarily are going to take it for six months, and then you're going to evaluate
A companion formula assumes the medication is already doing that work and covers what the medication leaves behind
The STEP 1 trial used 2.4 mg as the target maintenance dose and achieved average weight loss of 14.9% of body weight over 68 weeks
In the Phase 2 obesity trial, which followed adults with obesity or overweight for 48 weeks, the average reductions in body weight were striking: To put that in perspective, at the 12 mg dose, more than eight in ten participants lost at least 15% of their starting body weight
"We might find some real problems if we are not monitoring the body composition, especially for the older patients," Ahmed says